Ultragenyx Pharmaceutical...

NASDAQ: RARE · Real-Time Price · USD
36.84
-0.30 (-0.81%)
At close: Jun 23, 2025, 3:59 PM
37.07
0.64%
Pre-market: Jun 24, 2025, 09:18 AM EDT

Ultragenyx Pharmaceutical Stock Forecast

Stock Price Forecast

The 14 analysts with 12-month price forecasts for RARE stock have an median target of 79, with a low estimate of 48 and a high estimate of 136. The median target predicts an increase of 114.44% from the current stock price of 36.84.

Target Low Average Median High
Price 48 87 79 136
Change 30.29% 136.16% 114.44% 269.16%

Latest Analyst Insight Report

Guggenheim maintains a Buy rating on Ultragenyx Ph... Unlock content with Pro Subscription

Updated Jun 20, 2025

Rating Dec 24 Jan 25 Feb 25 Mar 25 May 25 Jun 25
Strong Buy 001000
Buy 223221
Hold 010000
Sell 000000
Strong Sell 000000
Total 2 3 4 2 2 1

Financial Forecast this Year

Revenue This Year
653.21M
from 560.23M
Increased by 16.6%
Revenue Next Year
836.92M
from 653.21M
Increased by 28.1%
EPS This Year
-5.01
from -6.29
Increased by 20.3%
EPS Next Year
-3.34
from -5.01
Increased by 33.3%